(Q38254942)

1 September 2017

1 reference

title

Ebola virus disease: potential use of melatonin as a treatment (English)

1 reference

1 September 2017

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

0 references

3

Russel J Reiter

1 reference

1 September 2017

2

Ahmet Korkmaz

1 reference

1 September 2017

4

Lucien C Manchester

1 reference

1 September 2017

1

Dun-Xian Tan

1 reference

1 September 2017

14 October 2014

1 reference

Journal of Pineal Research

1 September 2017

1 reference

1 September 2017

57

1 reference

1 September 2017

4

1 reference

1 September 2017

381-384

1 reference

A case of Ebola virus infection

1 September 2017

1 reference

Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.

21 January 2018

1 reference

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

21 January 2018

1 reference

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.

21 January 2018

1 reference

Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia.

21 January 2018

1 reference

Melatonin ameliorates angiotensin II-induced vascular endothelial damage via its antioxidative properties.

21 January 2018

1 reference

Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model.

21 January 2018

1 reference

The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury

21 January 2018

1 reference

Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats

21 January 2018

1 reference

Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury

21 January 2018

1 reference

Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men.

21 January 2018

1 reference

Effect of oral melatonin on the procoagulant response to acute psychosocial stress in healthy men: a randomized placebo-controlled study

21 January 2018

1 reference

Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium

21 January 2018

1 reference

Ebola hemorrhagic fever and septic shock

21 January 2018

1 reference

Role of the endothelium in viral hemorrhagic fevers

21 January 2018

1 reference

Effects of melatonin treatment in septic newborns.

21 January 2018

1 reference

Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis

21 January 2018

1 reference

Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"?

21 January 2018

1 reference

Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone.

21 January 2018

1 reference

The role of melatonin in the cells of the innate immunity: a review

21 January 2018

1 reference

Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JPI.12186

1 reference

1 September 2017

1 reference

PubMed ID

25262626